4.5 Article

Bright light therapy for agitation in dementia: a randomized controlled trial

期刊

INTERNATIONAL PSYCHOGERIATRICS
卷 21, 期 4, 页码 711-721

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1041610209008886

关键词

sleep disturbance; circadian rhythm

资金

  1. Mental Health Foundation

向作者/读者索取更多资源

Background: Agitation is common in people with dementia, is distressing to patients and stressful to their carers. Drugs used to treat the condition have the potential to cause particularly severe side effects in older people with dementia and have been associated with an increased death rate. Alternatives to drug treatment for agitation should be sought. The study aimed to assess the effects of bright light therapy on agitation and sleep in people with dementia. Methods: A single center randomized controlled trial of bright light therapy versus standard light was carried out. The study was completed prior to the mandatory registration of randomized controls on the clinical trials registry database and, owing to delays in writing up, retrospective registration was not completed. Results: There was limited evidence of reduction in agitation in people on active treatment, sleep was improved and a suggestion of greater efficacy in the winter months. Conclusions: Bright light therapy is a potential alternative to drug treatment in people with dementia who are agitated.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Health Care Sciences & Services

Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations

Lucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, Rob Howard, John T. O'Brien, Gail Mountain, Sube Banerjee, Bob Woods, Robert Perneczky, Louise Lafortune, Charlotte Roberts, Jenny McCleery, James Pickett, Frances Bunn, David Challis, Georgina Charlesworth, Katie Featherstone, Chris Fox, Claire Goodman, Roy Jones, Sallie Lamb, Esme Moniz-Cook, Justine Schneider, Sasha Shepperd, Claire Surr, Jo Thompson-Coon, Clive Ballard, Carol Brayne, Orlaith Burke, Alistair Burns, Linda Clare, Peter Garrard, Patrick Kehoe, Peter Passmore, Clive Holmes, Ian Maidment, Fliss Murtagh, Louise Robinson, Gill Livingston

HEALTH TECHNOLOGY ASSESSMENT (2017)

Article Geriatrics & Gerontology

Cognitive impairment and Charles Bonnet syndrome: a prospective study

Gregor Russell, Robert Harper, Harry Allen, Robert Baldwin, Alistair Burns

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)

Article Medicine, Research & Experimental

Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions

Andrew J. E. Harding, Hazel Morbey, Faraz Ahmed, Carol Opdebeeck, Ying-Ying Wang, Paula Williamson, Caroline Swarbrick, Iracema Leroi, David Challis, Linda Davies, David Reeves, Fiona Holland, Mark Hann, Ingrid Hellstrom, Lars-Christer Hyden, Alistair Burns, John Keady, Siobhan Reilly

TRIALS (2018)

Article Geriatrics & Gerontology

What is important to people living with dementia?: the long-list' of outcome items in the development of a core outcome set for use in the evaluation of non-pharmacological community-based health and social care interventions

Andrew J. E. Harding, Hazel Morbey, Faraz Ahmed, Carol Opdebeeck, Reena Lasrado, Paula R. Williamson, Caroline Swarbrick, Iracema Leroi, David Challis, Ingrid Hellstrom, Alistair Burns, John Keady, Siobhan T. Reilly

BMC GERIATRICS (2019)

Correction Public, Environmental & Occupational Health

Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice (vol 40, pg 679, 2017)

S. Jill Stocks, Evangelos Kontopantelis, Roger T. Webb, Anthony J. Avery, Alistair Burns, Darren M. Ashcroft

DRUG SAFETY (2019)

Article Geriatrics & Gerontology

Pathways to care for people with dementia: An international multicentre study

Umberto Volpe, Hania Amin, Olatunde O. Ayinde, Alistair Burns, Wai Chi Chan, Renaud David, Slavica Djukic Dejanovic, Gorica Djokic, Defne Eraslan, Giulia A. L. Fischer, Patricia Gracia-Garcia, Syed Usman Hamdani, Changsu Han, Hussain Jafri, Roy A. Kallivayalil, R. Kriekaart, Ee Heok Kua, Linda C. W. Lam, Dusica Lecic-Tosevski, Iracema Leroi, Antonio Lobo, Adriana Mihai, Fareed Aslam Minhas, Heena Mistry, Afolakemi T. Ogundele, Marcel G. M. Olde Rikkert, Javier Olivera, Claudia Palumbo, Angela Parker, Bojana Pejuskovic, Florian Riese, Philippe Robert, Maya Semrau, Gabriela Stoppe, Sanu Sudhakar, Andreea Raluca Tirintica, Sehrish Tofique, Chris Tsoi, Lucas Wolski, Irem Yalug, Huali Wang, Xin Yu, Norman Sartorius

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2020)

Article Medicine, General & Internal

Developing the evidence base for evaluating dementia training in NHS hospitals (DEMTRAIN): a mixed-methods study protocol

Faraz Ahmed, Hazel Morbey, Andrew Harding, David Reeves, Caroline Swarbrick, Linda Davies, Mark Hann, Fiona Holland, Ruth Elvish, Iracema Leroi, Simon Burrow, Alistair Burns, John Keady, Siobhan Reilly

BMJ OPEN (2020)

Article Geriatrics & Gerontology

Mild Cognitive Impairment: the Manchester consensus

Ross A. Dunne, Dag Aarsland, John T. O'Brien, Clive Ballard, Sube Banerjee, Nick C. Fox, Jeremy D. Isaacs, Benjamin R. Underwood, Richard J. Perry, Dennis Chan, Tom Dening, Alan J. Thomas, Jeffrey Schryer, Anne-Marie Jones, Alison R. Evans, Charles Alessi, Elizabeth J. Coulthard, James Pickett, Peter Elton, Roy W. Jones, Susan Mitchell, Nigel Hooper, Chris Kalafatis, Jill G. C. Rasmussen, Helen Martin, Jonathan M. Schott, Alistair Burns

Summary: MCI is a clinically heterogeneous syndrome that can lead to further cognitive decline, but may also remain stable or resolve over time. Diagnostic criteria, including cognitive testing, neuroimaging, and fluid biomarkers, can improve accuracy of diagnosis and potentially guide prognosis. Large-scale studies are needed to determine the practical usefulness of combining multiple markers for clinical use.

AGE AND AGEING (2021)

Article Geriatrics & Gerontology

A novel hybrid scale for the assessment of cognitive and executive function: The Free-Cog

Alistair Burns, Judith R. Harrison, Catherine Symonds, Julie Morris

Summary: The Free-Cog scale is a non-proprietary assessment tool that uniquely combines cognitive and executive function questions. It showed good discriminative ability between patient groups and could be useful in evaluating individuals with cognitive impairment.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2021)

Article Geriatrics & Gerontology

COVID-19 and dementia: experience from six European countries

Alistair Burns, Antonio Lobo, Marcel Olde Rikkert, Philippe Robert, Norman Sartorius, Maya Semrau, Gabriela Stoppe

Summary: The effects of COVID-19 on older people, especially those with dementia, are disproportionately negative, impacting health outcomes, care decisions, and leading to potential long-term neurological damage. Different responses to the pandemic from healthcare and social care systems in various countries highlight the need for specific attention to the presentation of the virus in older individuals and those with dementia, as well as the challenges of isolation and complex healthcare responses to minimize negative impacts. The identification of potential new working methods during the pandemic could offer a positive legacy from the crisis.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2021)

Review Geriatrics & Gerontology

Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gaps

Kathy Y. Liu, Robert Howard, Sube Banerjee, Adelina Comas-Herrera, Joanne Goddard, Martin Knapp, Gill Livingston, Jill Manthorpe, John T. O'Brien, Ross W. Paterson, Louise Robinson, Martin Rossor, James B. Rowe, David J. Sharp, Andrew Sommerlad, Aida Suarez-Gonzalez, Alistair Burns

Summary: The working group conducted a review on the impact of the COVID-19 pandemic on dementia wellbeing through studying 141 research articles within six domains. The study highlights the need for future research to address outstanding questions and develop evidence-based measures to improve the quality of life for dementia-affected individuals.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2021)

Article Public, Environmental & Occupational Health

The older prisoner health and social care assessment and plan (OHSCAP) versus treatment as usual: a randomised controlled trial

Katrina Forsyth, Roger T. Webb, Laura Archer Power, Richard Emsley, Jane Senior, Alistair Burns, David Challis, Adrian Hayes, Rachel Meacock, Elizabeth Walsh, Stuart Ware, Jenny Shaw

Summary: This study aimed to explore how to identify and address the health and social care needs of older adults in prison, but the implementation of OHSCAP did not lead to improved outcomes compared to TAU due to a range of issues.

BMC PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort

Artitaya Lophatananon, Krisztina Mekli, Rachel Cant, Alistair Burns, Curtis Dobson, Ruth Itzhaki, Kenneth Muir

Summary: The study found no significant association between shingles and dementia, however, individuals who had received Zostavax vaccination had a significantly reduced risk of developing dementia.

BMJ OPEN (2021)

Article Geriatrics & Gerontology

A suggested shared aetiology of dementia-a colocalization study

Xinzhu Yu, Artitaya Lophatananon, Krisztina Mekli, Alistair Burns, Kenneth R. Muir, Hui Guo

Summary: By investigating the potential shared causal genes between dementia or AD and traits such as stroke, diabetes, atherosclerosis, cholesterol level, and alcohol consumption, this study revealed the shared etiology between dementia and related diseases, providing evidence for the co-occurrence of multiple diseases.

NEUROBIOLOGY OF AGING (2022)

Article Public, Environmental & Occupational Health

Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice

S. Jill Stocks, Evangelos Kontopantelis, Roger T. Webb, Anthony J. Avery, Alistair Burns, Darren M. Ashcroft

DRUG SAFETY (2017)

暂无数据